The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Abstract
Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago. How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase. Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Paradoxically, decreased pyruvate kinase activity is associated with increased aerobic glycolysis, suggesting the activation of pyruvate kinase activity might be a way to target cancer (Christofk et al., 2008).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Christofk et al., 2008
In the citing paper
“Tumor cells engineered to exclusively express the M2 isoform display increased lactate production characteristic of the Warburg effect and gain a growth advantage in vivo over M1-expressing tumors (57).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [57]
In the citing paper
“PKM2 promotes the Warburg effect and tumorigenesis (Christofk et al., 2008; Hitosugi et al., 2009).”
From Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 (2011) · cites this paper as Christofk et al., 2008
In the citing paper
“Current data indicates that PKM2, when highly expressed, exists in an equilibrium of enzymatically inactive pyruvate kinase dimers (or monomers) which can translocate into the nucleus(Christofk et al., 2008; Hitosugi et al., 2009), and enzymatically active tetramers which are retained in the cytosol(Mazurek et al., 2005).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Christofk et al., 2008
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Self-citationMajumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,008
Hitosugi, T., Fan, J., Chung, T., Lythgoe, K., Wang, X., Xie, J., Ge, Q., Gu, T.-L., Polakiewicz, R. D., Roesel, J. L., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.015 · Cited by 337
PKM2 and cancer: The function of PKM2 beyond glycolysis
Dong, G., Mao, Q., XIA, W., Xu, Y., Wang, J., Xu, L., & JIANG, F. (2016) · Oncology Letters · doi:10.3892/ol.2016.4168 · Cited by 337
Advances in covalent kinase inhibitors
Abdeldayem, A., Raouf, Y. S., Constantinescu, S. N., Moriggl, R., & Gunning, P. T. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00720b · Cited by 337
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D.-S., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 332
Wei, Y., Wang, D., Jin, F., Bian, Z., Li, L., Liang, H., Li, M., Shi, L., Pan, C., Zhu, D., et al. (2017) · Nature Communications · doi:10.1038/ncomms14041 · Cited by 326
Human pyruvate kinase M2: A multifunctional protein
Gupta, V., & Bamezai, R. N. K. (2010) · Protein Science · doi:10.1002/pro.505 · Cited by 325
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
Vázquez, A., Liu, J., Zhou, Y., & Oltvai, Z. N. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-58 · Cited by 325
Wang, Y., Zhou, L., Zhao, Y., Wang, S., Chen, L.-L., Liu, L., Ling, Z., Hu, F., Sun, Y.-P., Zhang, J., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201387224 · Cited by 324
Tight junctions and the regulation of gene expression
Balda, M. S., & Matter, K. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.024 · Cited by 323
New aspects of the Warburg effect in cancer cell biology
Bensinger, S. J., & Christofk, H. R. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.003 · Cited by 322
Self-citationTherapeutic targets in cancer cell metabolism and autophagy
Cheong, H., Lü, C., Lindsten, T., & Thompson, C. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2285 · Cited by 320
Regulation of Liver Metabolism by Autophagy
Madrigal‐Matute, J., & Cuervo, A. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.09.042 · Cited by 319
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 317
Misregulation of Pre-mRNA Alternative Splicing in Cancer
Zhang, J., & Manley, J. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0253 · Cited by 316
S-Glutathionylation: From Molecular Mechanisms to Health Outcomes
Xiong, Y., Uys, J. D., Tew, K. D., & Townsend, D. M. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3540 · Cited by 314
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 316
Zhu, H., Shah, S. P., Shyh‐Chang, N., Shinoda, G., Einhorn, W. S., Viswanathan, S. R., Takeuchi, A., Grasemann, C., Rinn, J. L., Lopez, M. F., et al. (2010) · Nature Genetics · doi:10.1038/ng.593 · Cited by 310
Bernardos, A., Mondragón, L., Aznar, E., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., Soto, J., Baviera, J. M. B., Pérez‐Payá, E., Guillem, C., et al. (2010) · ACS Nano · doi:10.1021/nn101499d · Cited by 310
Alternative splicing in cancer: implications for biology and therapy
Chen, J., & Weiss, W. A. (2014) · Oncogene · doi:10.1038/onc.2013.570 · Cited by 309
Metabolic Pathway Alterations that Support Cell ProliferationPreprint
Heiden, M. G. V., Lunt, S. Y., Dayton, T. L., Fiske, B. P., Israelsen, W. J., Mattaini, K. R., Vokes, N. I., Stephanopoulos, G. N., Cantley, L. C., Metallo, C. M., et al. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010900 · Cited by 309
Self-citationMasson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 305
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Kim, J., Kim, J., & Bae, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.119 · Cited by 304
PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis
Liu, F., Ma, F., Wang, Y., Hao, L., Zeng, H., Jia, C., Wang, Y., Liu, P., Ong, I. M., Li, B., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3630 · Cited by 306
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 303
Agnihotri, S., & Zadeh, G. M. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov125 · Cited by 302
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 299
Pastò, A., Bellio, C., Pilotto, G., Ciminale, V., Silic‐Benussi, M., Guzzo, G., Rasola, A., Frasson, C., Nardo, G., Zulato, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2010 · Cited by 298
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Wang, Z., & Dong, C. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.003 · Cited by 300
Techniques to Monitor Glycolysis
TeSlaa, T. A., & Teitell, M. A. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00005-4 · Cited by 293
Agnihotri, S., Burrell, K. E., Wolf, A., Jalali, S., Hawkins, C. E., Rutka, J. T., & Zadeh, G. M. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0203-0 · Cited by 293
PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation
Damasceno, L. E. A., Prado, D. D. S., Veras, F. P., Fonseca, M. M., Toller-Kawahisa, J. E., Rosa, M. H., Públio, G. A., Martins, T. V., Ramalho, F. S., Waisman, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190613 · Cited by 293
Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer
Chaneton, B., & Gottlieb, E. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.04.003 · Cited by 292
Hedgehog Controls Hepatic Stellate Cell Fate by Regulating Metabolism
Chen, Y., Choi, S. S., Michelotti, G. A., Chan, I. S., Swiderska‐Syn, M., Karaca, G., Xie, G., Moylan, C. A., Garibaldi, F., Premont, R. T., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.115 · Cited by 289
Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
Villa, E., Ali, E. S., Sahu, U., & Ben‐Sahra, I. (2019) · Cancers · doi:10.3390/cancers11050688 · Cited by 289
Lin, R., Elf, S., Shan, C., Kang, H.-B., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J. H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3255 · Cited by 287
Watch What You (Self-) Eat: Autophagic Mechanisms that Modulate Metabolism
Lahiri, V., Hawkins, W. D., & Klionsky, D. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.003 · Cited by 287
Signaling in Control of Cell Growth and MetabolismPreprint
Ward, P. S., & Thompson, C. B. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006783 · Cited by 289
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer
Chen, X., Tian, M., Sun, R., Zhang, M., Zhou, L., Jin, L., Chen, L., Zhou, W., Duan, K., Chen, Y., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745124 · Cited by 285
Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells
Metallo, C. M., Walther, J. L., & Stephanopoulos, G. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.07.010 · Cited by 280
Ciavardelli, D., Rossi, C., Barcaroli, D., Volpe, S., Consalvo, A., Zucchelli, M., Cola, A. D., Scavo, E., Carollo, R., D'Agostino, D., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.285 · Cited by 279
Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3024 · Cited by 277
Mitochondrial pyruvate transport: a historical perspective and future research directions
McCommis, K. S., & Finck, B. N. (2015) · Biochemical Journal · doi:10.1042/bj20141171 · Cited by 277
The Role of p53 in Metabolic Regulation
Puzio-Kuter, A. M. (2011) · Genes & Cancer · doi:10.1177/1947601911409738 · Cited by 273
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
Sutendra, G., & Michelakis, E. D. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00038 · Cited by 275
Lim, S., Li, C., Xia, W., Lee, H., Chang, S.-S., Shen, J., Hsu, J. L., Raftery, D., Djukovic, D., Gu, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2478 · Cited by 270
Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis
Hu, H., Zhu, W., Qin, J., Chen, M., Gong, L., Li, L., Liu, X., Tao, Y., Yin, H., Zhou, H., et al. (2016) · Hepatology · doi:10.1002/hep.28887 · Cited by 271
Yang, C. G., Huang, X., Yan, L., Chen, J., Lv, Y., & Dai, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa164 · Cited by 269
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
Xie, B., Wang, S., Jiang, N., & Li, J. J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.019 · Cited by 268
Corrionero, A., Miñana, B., & Valcárcel, J. (2011) · Genes & Development · doi:10.1101/gad.2014311 · Cited by 268
Henao‐Mejia, J., Williams, A., Goff, L. A., Staron, M. M., Licona-Limón, P., Kaech, S. M., Nakayama, M., Rinn, J. L., & Flavell, R. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.021 · Cited by 267
Metabolic Kinases Moonlighting as Protein Kinases
Lu, Z., & Hunter, T. R. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.01.006 · Cited by 266
Llorian, M., Schwartz, S., Clark, T. A., Hollander, D., Tan, L.-Y., Spellman, R., Gordon, A., Schweitzer, A. C., de la Grange, P., Ast, G., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1881 · Cited by 263
Taylor, S., Spugnini, E. P., Assaraf, Y. G., Azzarito, T., Rauch, C., & Fais, S. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.004 · Cited by 263
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M. P., Hecht, V. C., Xu, K., Acevedo, P. N. M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 263
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 263
Stringari, C., Edwards, R. A., Pate, K. T., Waterman, M. L., Donovan, P. J., & Gratton, E. (2012) · Scientific Reports · doi:10.1038/srep00568 · Cited by 258
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
Akins, N. S., Nielson, T. C., & Le, H. V. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180523111351 · Cited by 258
The ins and outs of serine and glycine metabolism in cancer
Geeraerts, S. L., Heylen, E., Keersmaecker, K. D., & Kampen, K. R. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00329-9 · Cited by 258
Prigione, A., Rohwer, N., Hoffmann, S., Mlody, B., Drews, K., Bukowiecki, R., Blümlein, K., Wanker, E. E., Ralser, M., Cramer, T., et al. (2013) · Stem Cells · doi:10.1002/stem.1552 · Cited by 256
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Bluemlein, K., Grüning, N., Feichtinger, R. G., Lehrach, H., Kofler, B., & Ralser, M. (2011) · Oncotarget · doi:10.18632/oncotarget.278 · Cited by 255
Alfarouk, K. O., Verduzco, D., Rauch, C., Muddathir, A. K., Bashir, A. H. H., Elhassan, G. O., Ibrahim, M. E., Orozco, J. D. P., Cardone, R. A., Reshkin, S. J., et al. (2014) · Oncoscience · doi:10.18632/oncoscience.109 · Cited by 255
Calabretta, S., Bielli, P., Passacantilli, I., Pilozzi, E., Fendrich, V., Capurso, G., Fave, G. D., & Sette, C. (2015) · Oncogene · doi:10.1038/onc.2015.270 · Cited by 254
Emerging role of lipid metabolism alterations in Cancer stem cells
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., Zhou, Y., Zeng, Z., Peng, S., Li, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0784-5 · Cited by 253
Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
Tabas, I. A., & Bornfeldt, K. (2020) · Circulation Research · doi:10.1161/circresaha.119.315939 · Cited by 253
Emerging roles of Myc in stem cell biology and novel tumor therapies
Yoshida, G. J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0835-y · Cited by 252
Transketolase counteracts oxidative stress to drive cancer development
Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., Law, C.-T., Wong, C.-M., Cai, Z., Wong, C. C.-L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508779113 · Cited by 251
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 252
PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation
Li, T., Han, J., Jia, L., Hu, X., Chen, L., & Wang, Y. (2019) · Protein & Cell · doi:10.1007/s13238-019-0618-z · Cited by 251
Yang, W., Xia, Y., Cao, Y. J., Zheng, Y., Bu, W., Zhang, L., You, M. J., Koh, M. Y., Cote, G. J., Aldape, K., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.028 · Cited by 250
Qiu, G., Jin, M., Dai, J., Sun, W., Feng, J., & Jin, W. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 250
Zhang, H., Wang, D., Li, M., Plecitá‐Hlavatá, L., D’Alessandro, A., Tauber, J. A., Riddle, S. R., Kumar, S., Flockton, A. R., McKeon, B. A., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.028069 · Cited by 250
Cancer metabolism: Key players in metabolic reprogramming
Soga, T. (2012) · Cancer Science · doi:10.1111/cas.12085 · Cited by 247
Spike, B. T., Engle, D. D., Lin, J., Cheung, S. K., La, J., & Wahl, G. M. (2012) · Cell stem cell · doi:10.1016/j.stem.2011.12.018 · Cited by 246
Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells
Abekura, F., Kim, H.-D., Chang, Y., & Kim, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710037 · Cited by 250
Hu, S., Balakrishnan, A., Bok, R. A., Anderton, B., Larson, P. E. Z., Nelson, S. J., Kurhanewicz, J., Vigneron, D. B., & Goga, A. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.012 · Cited by 245
Iansante, V., Choy, P. M., Fung, S. W., Liu, Y., Chai, J.-G., Dyson, J., Río, A. D., D’Santos, C. S., Williams, R. L., Chokshi, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8882 · Cited by 245
Identification of small molecule inhibitors of pyruvate kinase M2
Heiden, M. G. V., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 245
Self-citationPKM2, a Central Point of Regulation in Cancer Metabolism
Wong, N., Melo, J. D., & Tang, D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/242513 · Cited by 245
Metabolic reprogramming in triple-negative breast cancer
Sun, X., Wang, M., Wang, M., Yu, X., Guo, J., Sun, T., Li, X., Yao, L., Dong, H., & Xu, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00428 · Cited by 243
Lucarelli, G. T., Galleggiante, V., Rutigliano, M., Sanguedolce, F., Cagiano, S., Bufo, P., Lastilla, G., Maiorano, E., Ribatti, D., Giglio, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3823 · Cited by 243
Is Cancer a Metabolic Disease?
Coller, H. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.035 · Cited by 244
Chen, M., Zhang, J., & Manley, J. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2513 · Cited by 242
Dysregulated lipid metabolism in cancer
Zhang, F. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i8.167 · Cited by 241
PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells
Jiang, Y., Li, X., Yang, W., Hawke, D. H., Zheng, Y., Xia, Y., Aldape, K., Wei, C., Guo, F., Chen, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.001 · Cited by 240
The Glycolytic Switch in Tumors: How Many Players Are Involved?
Yu, L., Chen, X., Sun, X., Wang, L., & Chen, S. (2017) · Journal of Cancer · doi:10.7150/jca.21125 · Cited by 240
Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Bose, S., Zhang, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_1 · Cited by 240
Exploring Disease through Metabolomics
Vinayavekhin, N., Homan, E. A., & Saghatelian, A. (2009) · ACS Chemical Biology · doi:10.1021/cb900271r · Cited by 238
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Goldberg, M. S., & Sharp, P. A. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111487 · Cited by 238
Kefas, B. A., Comeau, L., Erdle, N., Montgomery, E. A., Amos, S., & Purow, B. W. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq080 · Cited by 238
Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
Tamada, M., Suematsu, M., & Saya, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0859 · Cited by 238
Billiard, J., Dennison, J. B., Briand, J., Annan, R. S., Chai, D., Colón, M., Dodson, C. S., Gilbert, S. A., Greshock, J. D., Jing, J., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-19 · Cited by 237
Exploitation of EP300 and CREBBP Lysine Acetyltransferases by CancerPreprint
Attar, N., & Kurdistani, S. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026534 · Cited by 237
Granchi, C., Roy, S., Giacomelli, C., Macchia, M., Tuccinardi, T., Martinelli, A., Lanza, M., Betti, L., Giannaccini, G., Lucacchini, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101007q · Cited by 236
Hamabe, A., Konno, M., Tanuma, N., Shima, H., Tsunekuni, K., Kawamoto, K., Nishida, N., Koseki, J., Mimori, K., Gotoh, N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407717111 · Cited by 235
Apoptosis: its origin, history, maintenance and the medical implications for cancer and aging
Kaczanowski, S. (2016) · Physical Biology · doi:10.1088/1478-3975/13/3/031001 · Cited by 235
The Role of Mitochondria in Inflammation: From Cancer to Neurodegenerative Disorders
Missiroli, S., Genovese, I., Perrone, M., Vezzani, B., Vitto, V. A. M., & Giorgi, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030740 · Cited by 235
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234
Metabolic transformation in cancer
Tennant, D. A., Durán, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 235
Guo, D., Hildebrandt, I. J., Prins, R. M., Soto, H., Mazzotta, M. M., Dang, J., Czernin, J., Shyy, J. Y.-J., Watson, A. D., Phelps, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906606106 · Cited by 232
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Smolková, K., Plecitá‐Hlavatá, L., Bellancé, N., Bénard, G., Rossignol, R., & Ježek, P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 232
Metadata
- Authors
- Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Broad Institute (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7184
- Pages
- 230-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015207840
- Cited by
- 2,820
- References
- 20
- Citations by year
- 2026: 68 · 2025: 101 · 2024: 133 · 2023: 142 · 2022: 151 · 2021: 174 · 2020: 169 · 2019: 170 · 2018: 190 · 2017: 158 · 2016: 180 · 2015: 204 · 2014: 211 · 2013: 187 · 2012: 186
- FWCI
- 44.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- PKM2, alternative splicing, cancer metabolism, Warburg effect, aerobic glycolysis, carcinogenesis, phosphotyrosine binding, lactic acid production, oxygen consumption, glucose uptake, oxidative phosphorylation, tumor growth, glycolysis, tumor cell proliferation, tumor hypoxia
- MeSH terms
- Animals, Fructosediphosphates, Glycolysis, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Oxygen Consumption, Pyruvate Kinase, Gene Expression Regulation, Neoplastic, Alternative Splicing, Pyruvic Acid, Lactic Acid, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
